GGrantIndex
← Search

PHASE 1 OF SORAFENIB PLUS 17AAG IN SOLID TUMOR PATIENTS

$20,301M01FY2006RRNIH

University Of Maryland Baltimore, Baltimore MD

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →